What does CUSIP 00182C103 represent in this 13F holders report?

CUSIP 00182C103 is the security identifier for ANIP - ANI PHARMACEUTICALS INC - Common Stock used to aggregate holder disclosures.

How many institutions held ANIP - ANI PHARMACEUTICALS INC - Common Stock in Q1 2022?

115 institutional investors reported ANIP - ANI PHARMACEUTICALS INC - Common Stock for Q1 2022. Use the holders table for investor-level position and value details.

ANI PHARMACEUTICALS INC - Common Stock (ANIP)

CUSIP: 00182C103

Q1 2022 13F Holders as of 31 Mar 2022

Type / Class: Equity / Common Stock
Shares outstanding: 22,278,088
Total 13F shares: 9,205,000
Share change: +228,300
Total reported value: $258,822,043
Put/Call ratio: 387%
Price per share: $28.11
Number of holders: 115
Value change: -$5,750,270
Number of buys: 63
Number of sells: 61

Quarterly Holders Quick Answers

What is CUSIP 00182C103?
CUSIP 00182C103 identifies ANIP - ANI PHARMACEUTICALS INC - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2022
Previous quarter: Q4 2021

Recent filing periods for CUSIP 00182C103:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of ANIP - ANI PHARMACEUTICALS INC - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
BlackRock Finance, Inc.	13F	Company	7.6%	1,686,613	$77,721,000	—	31 Dec 2021	13F
VANGUARD GROUP INC	13F	Company	3.2%	716,776	$33,029,000	—	31 Dec 2021	13F
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC	13F	Company	2%	451,444	$20,803,000	—	31 Dec 2021	13F
STATE STREET CORP	13F	Company	2%	437,580	$20,164,000	—	31 Dec 2021	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	1.7%	389,304	$17,940,000	—	31 Dec 2021	13F
FIRST WILSHIRE SECURITIES MANAGEMENT INC	13F	Company	1.5%	328,494	$15,137,000	—	31 Dec 2021	13F
Rubric Capital Management LP	13F	Company	1.4%	307,557	$14,172,000	—	31 Dec 2021	13F
TANG CAPITAL MANAGEMENT LLC	13F	Company	1.3%	300,000	$13,824,000	—	31 Dec 2021	13F
Global Alpha Capital Management Ltd.	13F	Company	1.3%	284,831	$13,125,000	—	31 Dec 2021	13F
AMERIPRISE FINANCIAL INC	13F	Company	1.3%	283,077	$13,045,000	—	31 Dec 2021	13F
THOMPSON SIEGEL & WALMSLEY LLC	13F	Company	1.3%	279,554	$12,882,000	—	31 Dec 2021	13F
FEDERATED HERMES, INC.	13F	Company	1.2%	263,777	$12,155,000	—	31 Dec 2021	13F
DEUTSCHE BANK AG\	13F	Company	1%	226,640	$10,443,000	—	31 Dec 2021	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.91%	203,453	$9,375,000	—	31 Dec 2021	13F
Bank of New York Mellon Corp	13F	Company	0.63%	141,379	$6,515,000	—	31 Dec 2021	13F
Parkman Healthcare Partners LLC	13F	Company	0.62%	137,226	$6,323,000	—	31 Dec 2021	13F
NORTHERN TRUST CORP	13F	Company	0.56%	125,759	$5,795,000	—	31 Dec 2021	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.5%	111,480	$5,137,000	—	31 Dec 2021	13F
Ranger Investment Management, L.P.	13F	Company	0.5%	110,751	$5,103,000	—	31 Dec 2021	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.44%	98,502	$4,539,000	—	31 Dec 2021	13F
Brandywine Global Investment Management, LLC	13F	Company	0.44%	97,094	$4,474,000	—	31 Dec 2021	13F
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC	13F	Company	0.44%	96,910	$4,466,000	—	31 Dec 2021	13F
Russell Investments Group, Ltd.	13F	Company	0.42%	94,654	$4,361,000	—	31 Dec 2021	13F
EMERALD MUTUAL FUND ADVISERS TRUST	13F	Company	0.4%	89,491	$4,124,000	—	31 Dec 2021	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.39%	86,800	$4,000,000	—	31 Dec 2021	13F
EMERALD ADVISERS, LLC	13F	Company	0.37%	82,944	$3,822,000	—	31 Dec 2021	13F
PRINCIPAL FINANCIAL GROUP INC	13F	Company	0.35%	77,830	$3,586,000	—	31 Dec 2021	13F
MARATHON CAPITAL MANAGEMENT	13F	Company	0.34%	74,770	$3,445,000	—	31 Dec 2021	13F
Invesco Ltd.	13F	Company	0.31%	69,409	$3,199,000	—	31 Dec 2021	13F
KINGDON CAPITAL MANAGEMENT, L.L.C.	13F	Company	0.29%	65,000	$2,995,000	—	31 Dec 2021	13F
LSV ASSET MANAGEMENT	13F	Company	0.28%	63,300	$2,917,000	—	31 Dec 2021	13F
Walthausen & Co., LLC	13F	Company	0.28%	61,456	$2,832,000	—	31 Dec 2021	13F
Stonepine Capital Management, LLC	13F	Company	0.23%	52,290	$2,410,000	—	31 Dec 2021	13F
MARSHALL WACE, LLP	13F	Company	0.2%	44,600	$2,055,000	—	31 Dec 2021	13F
1492 Capital Management LLC	13F	Company	0.2%	43,611	$2,010,000	—	31 Dec 2021	13F
MORGAN STANLEY	13F	Company	0.19%	42,999	$1,981,000	—	31 Dec 2021	13F
Sio Capital Management, LLC	13F	Company	0.18%	40,000	$1,843,000	—	31 Dec 2021	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.17%	38,195	$1,760,000	—	31 Dec 2021	13F
D. E. Shaw & Co., Inc.	13F	Company	0.16%	35,939	$1,656,000	—	31 Dec 2021	13F
Nuveen Asset Management, LLC	13F	Company	0.16%	35,647	$1,603,000	—	31 Dec 2021	13F
PARAMETRIC PORTFOLIO ASSOCIATES LLC	13F	Company	0.16%	34,764	$1,602,000	—	31 Dec 2021	13F
JPMORGAN CHASE & CO	13F	Company	0.14%	32,147	$1,481,000	—	31 Dec 2021	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.13%	28,605	$1,319,000	—	31 Dec 2021	13F
Legal & General Group Plc	13F	Company	0.12%	26,340	$1,214,000	—	31 Dec 2021	13F
Cubist Systematic Strategies, LLC	13F	Company	0.12%	25,869	$1,192,000	—	31 Dec 2021	13F
Swiss National Bank	13F	Company	0.11%	25,200	$1,161,000	—	31 Dec 2021	13F
VICTORY CAPITAL MANAGEMENT INC	13F	Company	0.11%	25,129	$1,158,000	—	31 Dec 2021	13F
RHUMBLINE ADVISERS	13F	Company	0.11%	24,820	$1,144,000	—	31 Dec 2021	13F
CITADEL ADVISORS LLC	13F	Company	0.1%	23,126	$1,066,000	—	31 Dec 2021	13F
PUBLIC SECTOR PENSION INVESTMENT BOARD	13F	Company	0.1%	22,040	$1,016,000	—	31 Dec 2021	13F

Institutional Holders of ANI PHARMACEUTICALS INC - Common Stock (ANIP) as of Q1 2022

As of 31 Mar 2022, ANI PHARMACEUTICALS INC - Common Stock (ANIP) was held by 115 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 9,205,000 shares. The largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, DIMENSIONAL FUND ADVISORS LP, STATE STREET CORP, THOMPSON SIEGEL & WALMSLEY LLC, EMERALD ADVISERS, LLC, Global Alpha Capital Management Ltd., FIRST WILSHIRE SECURITIES MANAGEMENT INC, and AMERIPRISE FINANCIAL INC. This page lists 115 institutional shareholders reporting positions in this security for the Q1 2022 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2022 vs Q4 2021 Across Filers

Q4 2021 holders

126

Q1 2022 holders

115

Holder diff

-11

Investor	Q4 2021 Shares	Q1 2022 Shares	Share Diff	Share Chg %	Q4 2021 Value $	Q1 2022 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.